Randomized controlled trial comparing somatostatin with octreotide in the prevention of complications after pancreatectomy

Hepato-Gastroenterology

Volumn 55, Issue 86-87, 2008, Pages 1818-1823

  Closset, Jean ^a   Journe, Stephane ^a   Mboti, Freddy ^a   El Nakadi, Issam ^a   Gelin, Michel ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

Octreotide; Pancreatic surgery; Pancreaticoduo denectomy; Somatostatin

Indexed keywords

AMYLASE; OCTREOTIDE; SOMATOSTATIN; TRIACYLGLYCEROL LIPASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; MALE; PANCREAS CANCER; PANCREAS FISTULA; PANCREAS TUMOR; PANCREATICODUODENECTOMY; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SURGICAL DRAINAGE; SURGICAL MORTALITY; SURGICAL RISK; TREATMENT FAILURE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; OCTREOTIDE; PANCREATICODUODENECTOMY; POSTOPERATIVE COMPLICATIONS; SOMATOSTATIN;

EID: 57049144834     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Gouillat C, Gigot JF: Pancreatic surgical complications: the case for prophylaxis. Gut 2001; 49(Suppl IV):iv32-iv39.
2. Van Hee R, De Laet I, Salgado R, Ysebaert D: The influence of somatostatin on postoperative outcome after elective pancreatic surgery. Acta Chir Belg 1998; 98:62-65.
3. Yamagushi M, Nakano H, Midorikawa T, Yochizawa Y, Sanado Y, Kumada K: Prediction of pancreatic fistula by amylase levels of drainage fluid on the first day after pancreatectomy. Hepatogastroenterology 2003; 50:1155-1158.
4. Büchler M, Friess H, Klempa I, Hermanek P, Sulkowski U, Becker H, Schafmayer A, Baca I, Lorenz D, Meister R et al: Role of octreotide in the prevention of postoperative complications following pancreatic resection. Am J Surg 1993; 163:125-130.
5. Montorsi M, Zago M, Mosca F, Capussotti L, Zotti E, Ribotta G, Fegiz G, Fissi S. Roviaro G, Perrachia A: Efficacy of octreotide in the prevention of pancreatic fistula after elective pancreatic resections: a prospective, controlled, randomized clinical trial. Surgery 1995; 117:26-31.
6. Yeo CJ, Cameron JL, Lillemoe KD, Sauer P, Coleman J, Sohn T, Campbell KA, Choti MA: Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Ann Surg 2000; 232:419-429.
7. Lowy AM, Lee JE, Pisters PWT, Davidson BS, Fenoglio CJ, Stanford P: Prospective, randomised trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease. Ann Surg 1997; 226:632-641.
8. Li-ing J, Irving M: Somatostatin and octreotide in the prevention of postoperative pancreatic complications and the treatment of enterocutaneous pancreatic fistulas: a systematic review of randomized controlled trials. Br J Surg 2001; 88:190-199.
9. Klempa I, Schwedes U, Usadel KH: Verhutung von post-operativen pankreatischen kmplikationen nach duodenopankreatektomie durch somatostatin. Chirurg 1979; 50:427-432.
10. Friess H, Klempa I, Hermanek P, Sulkowski U, Uhl W, Beger HG, Buchler MW: Prophylaxis of complications after pancreatic surgery: results of a multicenter trials in Germany. Digestion 1994; 55(Suppl 1):35-40.
11. Connor S, Alexakis N, Garden OJ, Leandros E, Bramis J, Wigmore SJ: Meta-analysis of the value of somatostatine and its analogues in reducing complications associated with pancreatic surgery. Br J Surg 2005; 92:1059-1067.
12. Amirata E, Livingston DH, Eleavage J: Octreotide acetate decreases pancreatic complications after pancreatic trauma. Am J Surg 1994; 168:345-347.
13. Shan YS, Sy ED, Lin PW: Role of somatostatin in the prevention of pancreatic stump-related morbidity following elective pancreaticoduodenectomy in high-risk patients and elimination of surgeon-related factors: prospective, randomised, controlled trial. World J Surg 2003; 27:709-714.
14. Gouillat C, Chipponi J, Baulieux J, Parstensky C, Sarik J, Gayet B: Randomizedcontrolled multicentre trial of somatostatin infusion after pancreaticoduodenectomy. Br J Surg 2001; 88:1456-1462.
15. Bassi C, Falconi M, Lombardi D, Briani G, Vesentini S, Camboni MG, Pederzoli P: Prophylaxis of complications after pancreatic surgery: results of a multicenter trials in Italy. Digestion 1994; 55(Suppl 1):41-47.
16. Pederzolli P, Bassi C, Falconi M, Cambroni M: Efficacy of octreotide in the prevention of complications of elective pancreatic surgery. Br J Surg 1994; 81:265-269.
17. Le Moine O, Matos C, Closset J, Deviere J: Endoscopic management of pancreatic fistula after pancreatic and other abdominal surgery. Best Pract Res Clin Gastroenterol 2004; 18:957-975.
18. Yeo CJ: Does prophylactic octreotide benefit patients undergoing elective pancreatic resection? J Gastrointest Surg 1999; 3:223-224.
19. Geisler JP, Manahan KJ: Increasing somatostatin analogues until effective. Gynecol Oncol 2005; 96:906
20. Rosenberg GL, McNeil P, Turcotte L: Economic evaluation of the use of octreotide for prevention of complications following pancreatic resection. JGastrointest Surg 1999; 3:225-232.